The 32nd Annual Scientific Meeting of the American Pain Society will “offer current information about the diagnosis, treatment, and management of acute pain, chronic cancer and noncancer pain, and recurrent pain.” This year’s meeting will be “an arena for interdisciplinary exchange among pain scientists and healthcare professionals.”
32nd Annual Scientific Meeting of the American Pain Society

32nd Annual Scientific Meeting of the American Pain Society | APS 2013

Conference Coverages

Current Pain Assessment Tools for Geriatric Patients Missing from Practices
Current Pain Assessment Tools for Geriatric Patients Missing from Practices
Although several reliable and valid pain assessment tools for cognitively intact and impaired geriatric patients are currently available, clinical evidence emphasized by Keela Herr, PhD, RN, FAAN, AGSF, co-director of the John A. Hartford Center for Geriatric Nursing Excellence at the University of Iowa College of Nursing, suggests those scales are not consistently administered throughout practice settings.
Lubiprostone Shown to Be Effective in Improving Bowel Movement Frequency and Other Symptoms of Opioid-Induced Constipation
Phase III study results show patients with chronic non-cancer pain and opioid-induced constipation (OIC) experienced improvements in spontaneous bowel movement frequency and other symptoms of OIC.
Physician Awareness of Demographic Influences on Pain Treatment Decisions Can Impact Care Delivery
While past studies suggest variability in physicians’ chronic pain treatment decisions based on patients’ sex and race, few have considered the degree of providers’ self-insight into the influence of such demographics on their treatment decisions.
Data Support Long-Term Efficacy for Opioid Therapy for Chronic Non-Cancer Pain
A literature review of randomized controlled trials and open-label studies of six months or longer duration finds good evidence that opioid therapy improves pain scores, with weaker evidence for its long-term effect on functional status.
Federal Funding in Pain Research Falls, But Project Pipeline Grows
Though the total National Institutes of Health (NIH) budget has stayed flat over the past several years, chronic pain research has enjoyed an expanded slice of the federal funding pie, as dollars committed to that portion of science grew from $279 million in 2008 to $396 million in 2012.
Multidisciplinary Approach to Opioid Reduction Can Achieve Dosage Goals
In light of issues concerning opioid misuse running parallel to the tenfold increase of prescription opioid use over the past 20 years, a team of researchers have developed an ongoing study examining results of a pilot program aimed at reducing patients’ use of pain medications.
REMS Program for Transmucosal Immediate-release Fentanyl Products is Operational, But Success Remains Uncertain
The TIRF REMS Access program is designed to streamline the prescribing process and ensure appropriate patients are safely provided with TIRF products, but it may be preventing patients from accessing needed medications.

Most Popular

$vacMongoViewPlus$ $vAR$